Determinants of an autism spectrum disorder diagnosis in childhood and adolescence: Evidence from the UK Millennium Cohort Study

被引:26
|
作者
Hosozawa, Mariko [1 ,2 ]
Sacker, Amanda [1 ]
Mandy, William [1 ]
Midouhas, Emily [1 ]
Flouri, Eirini [1 ]
Cable, Noriko [1 ]
机构
[1] UCL, London, England
[2] Juntendo Univ, Tokyo, Japan
基金
美国国家卫生研究院; 英国经济与社会研究理事会; 英国医学研究理事会;
关键词
adolescents; autism spectrum disorder; diagnosis; Millennium Cohort Study; AGE; PREVALENCE; CHILDREN; US; IDENTIFICATION; EXPERIENCES; ADULTS;
D O I
10.1177/1362361320913671
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
This study aimed to identify determinants of a late autism spectrum disorder diagnosis, including diagnoses made 'very late' (i.e., in adolescence), using the Millennium Cohort Study, a nationally representative population-based cohort in the United Kingdom. Children diagnosed with autism spectrum disorder by age 14 (N = 581) were included and grouped by the parent-reported timing of diagnosis: before school (up to age 5), during primary school (age 5-11) and during secondary school (age 11-14). Predictors of diagnostic timing, at the child, family and school levels, were investigated using multinomial logistic regression. Most (79%) children with autism spectrum disorder were diagnosed after school entry, and 28% were not diagnosed until secondary school. Among those not diagnosed until secondary school, 75% had been identified at age 5 years by a parent and/or teacher as having socio-behavioural difficulties. Being diagnosed after starting school was predicted by living in poverty (adjusted relative risk ratio: primary = 1.90, 95% confidence interval: 1.03-3.53; secondary = 2.15, 1.05-4.42) and/or having no initial parental concerns (primary = 0.32, 0.15-0.70; secondary = 0.19, 0.09-0.43). Having typical-range intelligence also predicted diagnosis during secondary school. The result indicates that those without cognitive delays and poorer children were at risk of 'very late' (i.e. adolescent) diagnosis. Strategies to promote earlier identification, targeting age at primary school entry, could help those more likely to be diagnosed late. Lay abstract Despite policy emphasis on early identification, many children with autism spectrum disorder are diagnosed late, with some being diagnosed as late as in adolescence. However, evidence on what determines the timing of autism spectrum disorder diagnosis including children diagnosed in adolescence is lacking. Understanding these determinants, particularly in those diagnosed later than is ideal, can inform the development of effective strategies to improve earlier identification of autism spectrum disorder. This study used a nationally representative population-based cohort in the United Kingdom to explore child, family and school level predictors of timing of autism spectrum disorder diagnosis. In the United Kingdom, 79% of the children with autism spectrum disorder were diagnosed after entering primary school and 28% during secondary school. Among those not diagnosed until secondary school, 75% had shown social difficulties noticed by parents and/or teachers at age 5 years. The results suggest that healthcare providers should be aware that, even for universal systems of care, those living in poverty and having higher intelligence are most likely to miss out on a timely diagnosis. Strategies to promote earlier identification among school-aged children, including targeting primary school entry age (i.e. around age 5) and that encouraging referrals for a formal assessment at the first report of concerns over the child's social development may benefit those children who would otherwise be diagnosed later.
引用
收藏
页码:1557 / 1565
页数:9
相关论文
共 50 条
  • [1] Longitudinal analysis of cognitive development across childhood and adolescence: evidence from the UK Millennium Cohort Study
    Black, Michelle
    Adjei, Nicholas Kofi
    LANCET, 2022, 400 : 23 - 23
  • [2] Cyber offending predictors and pathways in middle adolescence: Evidence from the UK Millennium Cohort Study
    Maras, Katie
    Sweiry, Abe
    Villadsen, Aase
    Fitzsimons, Emla
    COMPUTERS IN HUMAN BEHAVIOR, 2024, 151
  • [3] Poverty dynamics and health in late childhood in the UK: evidence from the Millennium Cohort Study
    Lai, Eric T. C.
    Wickham, Sophie
    Law, Catherine
    Whitehead, Margaret
    Barr, Benjamin
    Taylor-Robinson, David
    ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 (11) : 1049 - +
  • [4] Medically assisted reproduction and mental health in adolescence: evidence from the UK Millennium Cohort Study
    Palma, Maria
    Fitzsimons, Emla
    Patalay, Praveetha
    Goisis, Alice
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2024, 65 (03) : 275 - 284
  • [5] Longitudinal predictors of weapon involvement in middle adolescence: Evidence from the UK Millennium Cohort Study
    Villadsen, Aase
    Fitzsimons, Emla
    AGGRESSIVE BEHAVIOR, 2023, 49 (01) : 5 - 14
  • [6] Maternal mental health and childhood injury: evidence from the UK Millennium Cohort Study
    Hope, Steven
    Deighton, Jessica
    Micali, Nadia
    Law, Catherine
    ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 (03) : 268 - +
  • [7] Overweight and obesity in childhood and adolescence: findings from the UK Millennium Cohort Study, up to age 14
    Pongiglione, Benedetta
    Fitzsimons, Emla
    LONGITUDINAL AND LIFE COURSE STUDIES, 2019, 10 (01): : 27 - 49
  • [8] Adverse childhood experiences, child poverty, and adiposity trajectories from childhood to adolescence: evidence from the Millennium Cohort Study
    Keyao Deng
    Rebecca E. Lacey
    International Journal of Obesity, 2022, 46 : 1792 - 1800
  • [9] Adverse childhood experiences, child poverty, and adiposity trajectories from childhood to adolescence: evidence from the Millennium Cohort Study
    Deng, Keyao
    Lacey, Rebecca E.
    INTERNATIONAL JOURNAL OF OBESITY, 2022, 46 (10) : 1792 - 1800
  • [10] Childhood Transitions Between Weight Status Categories: Evidence from the UK Millennium Cohort Study
    Onyimadu, Olu
    Astbury, Nerys M.
    Achana, Felix
    Petrou, Stavros
    Violato, Mara
    PHARMACOECONOMICS, 2024, 42 (06) : 649 - 661